<?xml version="1.0" encoding="UTF-8"?>
<p id="par0240">Chloroquine (CQ) and hydroxychloroquine (HCQ) are used to treat mainly malaria and rheumatic diseases, respectively and have a very similar chemical structure [
 <xref rid="bib0610" ref-type="bibr">122</xref>]. CQ showed to be able to inhibit MERS-CoV 
 <italic>in vitro</italic> in a dose-dependent manner. [
 <xref rid="bib0615" ref-type="bibr">123</xref>,
 <xref rid="bib0620" ref-type="bibr">124</xref>]. In addition, to MERS-CoV, no clinical data are available on the success of chloroquine to patients [
 <xref rid="bib0625" ref-type="bibr">125</xref>].
</p>
